Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N. van Hest
Prm109 - Exploring the Use and Acceptance of Alternative Survival Modelling Approaches for Immuno-Oncology Therapies in Uk Technology Assessments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Prm64 - The Need for Innovative Survival Modelling Approaches in Health Technology Assessments (Hta) of Early-Stage Oncology Indications
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm148 - Health Technology Assessment Agency Appraisal of Immuno-Oncology Cure Fraction Survival Modelling
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
Angewandte Chemie
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
Angewandte Chemie - International Edition
Catalysis
Chemistry
Immuno-Oncology: The Next Generation of Breakthrough Therapies. Highlights From the Society for Medicines Research Symposium. Oxford, UK - June 21, 2019
Drugs of the Future
Pharmacology
The Role of Radiation Oncology in Immuno‐Oncology
Oncologist
Cancer Research
Medicine
Oncology
Immuno‐oncology for Surgeons
British Journal of Surgery
Surgery
Immuno‐Oncology Forum
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Pcn303 - Assessing the Value of Novel Immuno-Oncology (I-O) Therapies: How Consistent Is the Health Technology Assessment (Hta) Bodies' Consideration of the Survival Benefit in the Absence of Long-Term Data?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
